RBC Capital Downgrades Arrowhead Research (ARWR) to Sector Perform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/29/2026
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- Fed chair Warsh kicks off Jackson Hole keynote address
- PayPal tumbles as Advent, Stripe said to drop $50 bln pursuit
- Oil settles lower on clues about Fed policy, rumors of Hormuz deal
- Dollar jumps after Warsh comments, set for weekly gain
- McKesson reports cybersecurity incident affecting its information systems
- Mizuho is bullish on Broadcom ahead of Sept. 2 earnings, citing 30-quarter streak
- BioNTech ends colorectal cancer mRNA therapy trial early
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- Pinterest CFO resigns, interim replacement named
Arrowhead Research (ARWR) Price Target Cut to $20 at Deutsche Bank; Program Isn't Dead, Says Analyst
October 8, 2014 1:16 PM EDTDeutsche Bank maintained a Buy rating on Arrowhead Research (NASDAQ: ARWR) but lowered its price target to $20.00 (from $45.00). Earlier Arrowhead Research reported disappointing ARC-520 data in a AASLD abstract. Analyst Alethia Young sees higher risks but doesn't think the program is dead.
"The viral reductions w/ ARC-520... More
Arrowhead Research (ARWR) Selloff Unwarranted - Jefferies
October 8, 2014 11:55 AM EDTJefferies said Arrowhead Research's (NASDAQ: ARWR) selloff is unwarranted and its price target is still $30.
... MoreRBC Notes Arrowhead Research (ARWR) Data is at Low End of Expectations
October 8, 2014 11:44 AM EDTAnalyst Michael J. Yee of RBC commented on Arrowhead Research (NASDAQ: ARWR) after the release of a later breaker AASLD abstract. Shares plunged 50% due to negative information in the report.
"ARWR data reported 1-2mg data from first two cohorts showing 39% and 51% mean reduction in... More
Arrowhead Research (ARWR) trading paused for volatility
October 8, 2014 11:00 AM EDTArrowhead Research (NASDAQ: ARWR) trading paused for volatility.
... MoreArrowhead Research (ARWR) Slammed Following AASLD Abstract Release, Shares Paused
October 8, 2014 10:28 AM EDTArrowhead Research (NASDAQ: ARWR) Slammed Following AASLD Abstract Release, Shares Paused
... MoreArrowhead Research (ARWR) to Present ARC-520 Phase 2a Data in Late-Breaking Session at AASLD
October 8, 2014 10:12 AM EDTArrowhead Research Corporation (NASDAQ: ARWR) today announced that data from the ongoing Phase 2a study of ARC-520, its RNAi therapeutic candidate for the treatment of chronic hepatitis B (HBV) infection, will be presented in the late-breaking poster session at the 2014 American Association for the Study of Liver Diseases (AASLD) Liver Meeting being held on November 7-11, 2014, in Boston. Arrowhead was also selected to deliver a plenary presentation with new preclinical efficacy data on ARC-AAT, its RNAi therapeutic candidate for the treatment of liver disease associated with... More
Arrowhead Research (ARWR) Late Breaker AASLD Status Not Expected Until 10 AM, Says Deutsche Bank
October 8, 2014 9:45 AM EDTArrowhead Research (NASDAQ: ARWR) late breaker status is expected at 10 AM, said analyst Alethia Young of Deutsche Bank in research report, noting differences compared to Intercept Pharma (NASDAQ: ICPT).
"While ICPT announced earlier today... More
